Protocol No.: D9311C00001

Title
DUO-E: A Randomized, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-Line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer
Principal Investigator
Galvan Turner, Valerie
Phase
III
Age Group
Adult
Applicable Disease Site
Gynecologic Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Deborah Moore, MS
Research Specialist
Phone: +1 304-293-0609

View on ClinicalTrials.gov